Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Consequences of CYP2C19 Variants on Limonene Metabolism in Humans

NCT05078723 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05078723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05078723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Consequences of CYP2C19 Variants on Limonene Metabolism in Humans
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Recruiting
Start date
October 30, 2021
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cyp2c19 genetic variants